Since the discovery of the mutated CFTR gene in cystic fibrosis patients, scientists have been working on the development of gene therapy for this patient group. Recently, a gene therapy phase II clinical trial with 116 participants in the UK resulted in the halt of disease progression, although there was little effect. The article was published in The Lancet. Continue reading
Showing articles tagged with 'Cftr'